Review of Sinopharm (1099.HK)

 I hold 30,000 shares in Sinopharm. My average cost is HK$21.2. The current price is $20.3. I have a loss of SGD $5,500 on this holding.

Sinopharm hit a low of $14.6 on 7 Oct. It has recovered 40% from this bottom.

The current price earning ratio is 6.77 times and the dividend yield is 4.2%. Sinopharm is expected to report better profit for the current financial year.

With the surge in covid infection in China, following the recent relaxation of covid restriction, I expect an increase demand for Sinopharm's products.

I will buy another 15,000 shares.

Note - I am sharing my personal investment decision. Do not treat it as " investment advice".

https://fisca.sg/ArticleDisplay.aspx?ID=1269